abstract |
FIELD: medicine, ophthalmology, medicinal biochemistry. n SUBSTANCE: invention relates to manufacturing ophthalmic composition used for reducing intraocular pressure. Invention proposes using inhibitors of glycogen synthase kinase-3. Proposed composition provides reducing intraocular pressure by increasing intraocular liquid efflux and to prevent loss of retina ganglion cells. n EFFECT: valuable medicinal properties of inhibitors. n 19 cl, 6 ex |